06:00 PM EDT, 04/19/2024 (MT Newswires) -- Julia G. Butchko, Chief Development Officer, on April 17, 2024, sold 10,115 shares in Immunovant ( IMVT ) for $293,923. Following the Form 4 filing with the SEC, Butchko has control over a total of 451,627 shares of the company, with 451,627 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1764013/000176401324000077/xslF345X03/wk-form4_1713563949.xml